Disturbance of inorganic phosphate metabolism in diabetes mellitus: Its impact on the development of diabetic late complications

Current Diabetes Reviews

Volumn 6, Issue 5, 2010, Pages 323-333

  Ditzel, Jørn ^a   Lervang, Hans Henrik ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

6 diphosphate; Diabetic late complications; Erythropoietin (EPO); Fructose 1; Hemoglobin A1c; Hypoxia; Inorganic phosphate metabolism

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; PHOSPHATE;

ARTICLE; BASAL METABOLIC RATE; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DIABETIC COMPLICATION; DIABETIC PATIENT; DIABETOGENESIS; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; HEART TISSUE; HEMOGLOBIN BLOOD LEVEL; HIGH ENERGY PHOSPHATE; HUMAN; HYPOXIA; KIDNEY TUBULE CELL; MUSCLE TISSUE; NORMAL HUMAN; OXYGEN CONSUMPTION; OXYGEN DISSOCIATION CURVE; PATHOGENESIS; PHOSPHATE METABOLISM; PLASMA; PRIORITY JOURNAL; SKIN; ANIMAL; BIOLOGICAL MODEL; DISEASE COURSE; DISORDERS OF MINERAL, ELECTROLYTE AND METAL METABOLISM; METABOLISM; ONSET AGE; REVIEW; TIME;

AGE OF ONSET; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; PHOSPHATES; PHOSPHORUS METABOLISM DISORDERS; TIME FACTORS;

EID: 79952118709     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339910793360833     Document Type: Article

References (116)

1. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes in insulin-dependent diabetes mellitus. N Engl J Med 1993; 320: 977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 1998; 352: 837-53.
3. Ditzel J, Sagild U. Morphologic and hemodynamic changes in the smaller blood vessels in diabetes mellitus II. The degenerative and hemodynamic changes in the bulbar conjunctiva of normotensive diabetic patients. N Engl J Med 1954; 250: 587-609.
4. Ditzel J. Functional microangiopathy in diabetes mellitus. Diabetes 1968; 17: 188-97.
5. Ditzel J, McMillan DE. Functional and early structural changes in diabetic microangiopathy. In: Rifkin H. Raskin P. Eds. Diabetes Mellitus. American Diabetes Association 1981; pp. 247-51.
6. Sandemann DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992; 327: 760-64.
7. Gabbay KH, Merola LO, Field RA. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 1966; 151: 209-10.
8. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
9. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
10. Du XL, Edelstein D, Rossetti I, et al. Hyperclycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator I inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000; 97: 12222-6.
11. Ditzel J. Affinity hypoxia as a pathogenetic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol (Copenh)1980; 238(Suppl): 39-55.
12. Williamson JR, Chang K, Frangos M, et al. Hyperglycemic pseu-dohypoxia and diabetic complications. Diabetes 1993; 42: 801-13.
13. Brownlee M. The pathobiology of diabetic complications. A unifying mechanism. Diabetes 2005; 54: 1615-25.
14. Tan AL, Forbes J, Cooper ME. AGE, RACE and ROS in diabetic nephropathy. Semin Nephrol 2007; 27: 130-43.
15. Ditzel J. Effect of plasma inorganic phosphate on tissue oxygenation during recovery from diabetic ketoacidosis. Adv Exp Med Biol 1973; 37A: 163-72.
16. Ditzel J, Standl E. The problems of tissue oxygenation in diabetes mellitus. II Evidence of disordered oxygen release from the erythrocytes of diabetics in various conditions of metabolic control. Acta Med Scand 1975; 578(Suppl): 59-68.
17. Ditzel J, Brøchner-Mortensen J, Rødbro P. Elevated glomerular filtration rate in early diabetes may be explained by increased sodium reabsorption secondary to impairment in renal tubular handling of phosphate. Hormone Metab Res 1981; 1(Suppl): 87-9.
18. Ditzel J, Brøchner-Mortensen J, Kawahara R. Dysfunction of tubular phosphate reabsorption related to glomerular filtration and blood glucose control in diabetic children. Diabetologia 1982; 23: 406-10.
19. Ditzel J, Brøchner-Mortensen J. Tubular reabsorption rates as related to elevated glomerular filtration in diabetic children. Diabetes 1983; 32(Suppl 2) 28-32.
20. Mathiassen B, Nielsen S, Johansen JS, et al. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabetes Complicat 1990; 4: 145-9.
21. Chance B, Leigh JS, Kent J, et al. Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. Proc Natl Acad Sci USA 1986; 83: 9458-62.
22. Cirillo M, Ciacci C, De Santo NG. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 2008; 359: 864-6.
23. Finch CA, Lenfant C. Oxygen transport in man. N Engl J Med 1972; 286: 407-15.
24. Adamson JW, Finch CA. Hemoglobin function, oxygen affinity, erythropoietin. Annu Rev Physiol 1975; 37: 351-69.
25. Wade JPH, du Boulay GH, Marshall J, et al. Cerebral blood flow, haematocrit and viscosity in subjects with a high oxygen affinity haemoglobin variant. Acta Neurol Scand 1980; 61: 210-5.
26. Ditzel J, Heuer P-E. Caliber changes in the cutaneous microvessels as related to changes in basal metabolism in diabetics. Bibl Anat 1975; 13: 219-21.
27. Ditzel J. Problem of tissue oxygenation in diabetes as related to development of diabetic retinopathy. In: Mausolf, FA, Ed. The Eye and Systemic Disease. CV Mosby Company, Saint Louis., Toronto, London 1980; pp. 179-85.
28. Skovborg F, Nielsen AV, Lauritzen E, Hartkopp O. Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 1969; 18: 292-8.
29. Cunha-Vaz JG. The microcirculation and pathology of the diabetic retina. In: Effros RM, Schmid-Schonbein H, Ditzel J. Eds. Microcirculation. Current physiologic, medical and surgical concepts. Academic Press 1982; pp. 205-27.
30. 1c and red cell oxygen release capacity in relation to early retinal changes in newly discovered overt and chemical diabetics. Metabolism 1979; 4(Suppl 1): 440-7.
31. Bunn HF, Briehl RW. The interaction of 2, 3-diphosphoglycerate with various human hemoglobins. J Clin Invest 1970; 49: 1088-95.
32. Ditzel J. Haemorheological factors in the development of diabetic microangiolathy. Br J Ophthalmol 1967; 51: 793-803.
33. Ditzel J, White P. Central retinal vein occlusion in juvenile diabetes. J Chron Dis 1956; 3: 253-62.
34. Larsen HW. The ophthaloscopic and fluorescein angiographic picture of diabetic retinopathy. Acta Med Scand 1975; 578(Suppl): S31-9.
35. Torrance J, Jacobs P, Restrepo A, et al. Intraerythrocytic adaptation to anemia. N Engl J Med 1970; 283: 165-9.
36. Sheldon GF, Sanders S, Fuchs R, Garcia J, Schooley J. Metabolism, oxygen transport and erythropoietin synthesis in anemia of thermal injury. Am J Surg 1978; 136: 408-11.
37. Metcalfe JD, Dhindsa DS, Edwards MJ, Mourdjinis A. Decreased affinity of blood for oxygen in patients with low-output heart failure. Circ Res 1969; 25: 47-51.
38. Woodson RD, Wranne B, Detter JC. The effect of cardiac disease on hemoglobin-oxygen binding. J Clin Invest 1970; 49:1344-56.
39. Oski FA, Gottlich AJ, Delivoria-Papadopoulos M, Miller WW. Red-cell 2, 3 diphosphoglycerate levels in subjects with chronic hypoxemia. N Engl J Med 1969; 280: 1165-6.
40. Valeri CR, Fortier NL. Red cell 2, 3-diphosphoglycerate and creatine levels in patients with red-cell mass deficits or with cardiopulmonary insufficiency. N Engl J Med 1969; 281: 1452-5.
41. Ditzel J. Impaired oxygen release caused by alterations of the metabolism in the erythrocytes in diabetes. Lancet 1972; 1: 721-3.
42. Alberti KGMM, Emerson PM, Darley JH, Hockaday TD. 2, 3-diphosphoglycerate and tissue oxygenation in uncontrolled diabetes. Lancet 1972; 2: 391-5.
43. Bellingham AJ, Detter JC, Lenfant C. The role of hemoglobin affinity for oxygen and red cell 2, 3-DPG in the management of diabetic ketoacidosis. Trans Assoc Am Physicians 1973; 83: 113-20.
44. Arthurson G, Garby L, Robert M, Zaar B. Oxygen affinity of whole blood and under standard conditions in subjects with diabetes mellitus. Scand J Clin Invest 1974; 34: 19-22.
45. Ditzel J, Standl E. The oxygen transport system of red blood cells during diabetic ketoacidosis and recovery. Diabetologia 1975; 11: 255-60.
46. Kanter Y, Bessman SP, Bessman AN. Red cell 2, 3-diphosphoglycerate levels among diabetic patients with and without vascular complications. Diabetes 1975; 24: 724-9.
47. Kanter Y, Gerson JR, Bessman AN. 2, 3-diphosphoglycerate, nucleotide phosphate, and organic and inorganic phosphate levels during early phases of diabetic ketoacidosis. Diabetes 1977; 26: 429-33.
48. Ditzel J. Changes in red cell oxygen release capacity in diabetes mellitus. Fed Proc 1979; 38: 2484-8.
49. Standl E, Ditzel J. The effect of red cell 2, 3-DPG changes induced by diabetic ketoacidosis on parameters of the oxygen dissociation curve in man. Adv Exp Med Biol 1976; 75: 89-95.
50. Resnick L, Gupta RK, Barbagallo M, Laragh JH. Is the higher incidence of ischemic disease in patients with hypertension and diabetes related to intracellular depletion of high energy metabolites? Am J Med Sci 1994; 307(suppl 1): S66-9.
51. Ditzel J, Hau C, Daugaard N. Effect of diphosphonate ethane-1-hydroxy 1,1 diphosphonate (EHDP) on hemoglobin oxygen affinity of diabetic and healthy subjects. Microvasc Res 1977; 13: 355-61.
52. Travis SF, Sugerman HJ, Ruberg R, et al. Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimenta-tion. N Engl J Med 1971; 285: 763-8.
53. Sheldon GF, Grzyb S. Phosphate depletion and repletion: relation to parenteral nutrition and oxygen transport. Ann Surg 1975; 182: 683-9.
54. Lichtman MA, Miller DR. Erythrocyte glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: Relationship to extra cellular phosphate concentration. J Lab Clin Med 1970; 76: 167-79.
55. Stamatoyannopoulus C, Bellingham AJ, Lenfant C, Finch CA. Abnormal hemoglobins with high and low oxygen affinity. Annu Rev Med 1971; 22: 221-34.
56. Ditzel J, Andersen H, Daugaard-Peters N. Oxygen affinity of haemoglobin and red cell 2, 3 diphosphoglycerate in childhood diabetes. Acta Paedr Scand 1975; 64: 355-61.
57. Ditzel J, Kawahara R, Mouritz-Andersen T, et al. Changes in blood glucose, glycosylated hemoglobin and hemoglobin-oxygen affinity following meals in diabetic children. Eur J Pediatr 1981;137: 131-4.
58. Graham JJ, Ryall RG, Wise PH. Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus. Diabetologia 1980; 18: 205-7.
59. Roberts AP, Story CJ, Ryall RG. Erythrocyte 2,3-bisphophoglycerate concentrations and haemoglobin glycosylation in normoxic Type 1(insulin-dependent) diabetes mellitus. Diabetologia 1984; 26: 389-91.
60. Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353: 782-92.
61. Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA 2008; 105: 6998-7003.
62. Dennis VW, Brazy PC. Sodium, phosphate, bicarbonate, and alanine. Interaction in the isolated proximal tubule of rabbit kidney. J Clin Invest 1978; 62: 387-97.
63. Barrett PQ, Aronson PS. Glucose and alanine inhibition of phosphate transport in renal microvillus membrane vesicles. Am J Physiol 1982; 242: F126-31.
64. + gradient-dependent transport of d-glucose in renal brush border membranes. J Biol Chem 1975; 250: 6032-9.
65. Brazy PC, Gullans SR, Mandell J, Dennis VW. Metabolic requirement for inorganic phosphate by rabbit proximal tubule. Evidence for a Crabtree effect. J Clin Invest 1982; 10: 53-62.
66. Brazy PC, Mandel LJ, Gullans SR, Soltoff P. Interactions between phosphate and oxidative metabolism in proximal renal tubules. Am J Physiol 1984; 247(4 Pt 2): F575-81.
67. Brazy PC. Mitochondrial metabolism and phosphate transport in proximal renal tubules. Am J Kidney Dis 1989; 14: 288-302.
68. Chobanian MC, Anderson ME, Brazy PC. An NMR study of cellular phosphates and membrane transport in renal proximal tubules. Am J Physiol (Renal, Fluid, Electrolyte Physiol.) 1995; 268: F375-84.
69. Brazy PC, Chobanian MC. Interaction between D-glucose and phosphate in renal proximal tubule cells. Kidney Int 1996; 50(Suppl 57): 30-4.
70. Körner A, Eklöf A-S, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994; 43: 629-33.
71. Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin Exp Pharmacol Physiol 2006; 33: 997-1001.
72. Gertner JM, Tamberlane WV, Horst R, Sherwin RS, Felig P, Genel M. Mineral metabolism in diabetes mellitus. Changes accompanying treatment with portable subcutaneous insulin infusion. J Clin Endocrinol Metab 1980; 50: 962-6.
73. Ditzel J, Standl E. Plasma Pi and erythrocyte 2,3DPG concentrations of non-acidotic diabetics in various degree of metabolic control. Clin Chem 1976; 22: 550-1.
74. Ditzel J, Jæger P, Standl E. An adverse effect of insulin on the oxygen-release capacity of red blood cells in nonacidotic diabetics. Metabolism 1978; 22: 927-34.
75. Raskin P, Pak CYC. The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus. Diabetologia 1981; 21: 50-3.
76. Nagasaka S, Murakami T, Uchikawa S, Ishikawa SE, Saito T. Effect of glycemic control on calcium and phosphorous handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr J 1995; 42: 377-83.
77. Metzler B, Schocke MFH, Steinboeck P, et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type 1. J Cardiovasc Magnet Reson 2002; 4: 493-502.
78. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328-35.
79. 31P magnetic resonance spectroscopy and direct quantification with high pressure liquid chromatography. Foot Ankle Int 1999; 20: 258-62.
80. Greenman RL, Panasyuk S, Wang X, et al. Early changes in the skin microcirculation and muscle metabolism in the diabetic foot. Lancet 2005; 366: 1711-7.
81. Lardy HA, Wellman M. Oxidative phosphorylation. Role of inorganic phosphate and acceptor systems in control of metabolic rates. J Biol Chem 1952; 195: 215-24.
82. Sestoft L. Regulation of fructose metabolism in the perfused rat liver. Interrelation with inorganic phosphate, glucose, ketone body and ethanol metabolism. Biochem Biophys Acta 1974; 343: 1-16.
83. Brazy PC, Mandel IJ. Does availability of inorganic phosphate regulate cellular oxidative metabolism? News Physiol Sci 1986; 1: 100-3.
84. Tanaka A, Chance B, Quistorff D. A possible role of inorganic phosphate as a regulator of oxidative phosphorylation in combined urea synthesis and gluconeogenesis in perfused rat liver. J Biol Chem 1989; 264: 10034-40.
85. Bose S, French S, Evans SJ, Joubert F, Balaban RS. Metabolic network control of oxidative phosphorylation; multiple roles of inorganic phosphate. J Biol Chem 2003; 278: 39155-65.
86. Sestoft L. Is the relationship between plasma concentration of inorganic phosphate and the rate of oxygen consumption of significance in regulating energy metabolism in mammals? Scand J Clin Invest 1979; 39: 191-7.
87. Firmat G, Prumier J, Rawson RW, Roberts KE, Schwartz MK. Effect of phosphate enhancing the action of triiodothyronine. Endocrinology 1956; 59: 565-70.
88. Mosekilde L, Christensen MS. Decreased parathyroid function in hyperthyroidism: Interrelationship between serum parathyroid hormone, calcium-phosphorous metabolism and thyroid function. Acta Endocrinol(Copenh) 1977; 84: 566-75.
89. Lukensmeyer WW, Hege JH, Theil GB, Wilson WR. Calcium and phosphorus metabolic studies in triiodothyronine-induced hyper-metabolism. Am J Med Sci 1970; 259: 282-91.
90. Lingärde F, Trell E. Serum inorganic phosphate in middle-aged men I Inverse relation to body weight. Acta Med Scand 1977; 202: 307-11.
91. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients. Diabetologia 1984; 27: 13-6.
92. Nair KS. Webster J, Garrow JS. Effect of impaired glucose tolerance and type II diabetes on resting metabolic rate and thermic response to a glucose meal in obese women. Metabolism 1986; 35: 640-4.
93. Takata K, Chiba N, Tawara M, et al. Comparison of energy metabolism in insulin-dependent and non-insulin-dependent diabetes mellitus. J Med Invest 1997; 44: 67-71.
94. Horstmann P. The effect of adrenaline on oxygen consumption in diabetes mellitus and in hyperthyroidism. Acta Endocr (Co-penh)1954; 16: 67-71.
95. Joslin EP. Diabetic metabolism with high and low diets. Carnegie Institution of Washington, 1923; Publ. 323.
96. Fontveille AM, Lillioja S, Ferrao RT, Schulz LO, Rising R, Ravus-sin E. Twenty-four hour energy expenditure in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 753-9.
97. Bitz C, Toubro S, Larsen TM, et al. Increased 24-h energy expenditure in Type 2 diabetes. Diabetes Care 2004; 27: 2416-21.
98. Rolfe DFS, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997; 77: 731-58.
99. Escoubet B, Djalbali K, Amiel C. Adaptation to Pi deprivation of cell Na-dependent Pi uptake: a widespread process. Am J Physiol 1989; 256(2 pt 1): 322-8.
100. Lingärde F, Trell E. Serum inorganic phosphate and serum calcium in middle-aged men. II Relation to glucose and insulin parameters in glucose tolerance tests. Acta Med Scand 1978; 203: 315-20.
101. DeFronzo RA, Lang R. Hypophosphatemia and glucose intolerance: evidence to tissue insensitivity to insulin. N Engl J Med 1980; 303: 1259-63.
102. Nowicki M, Fliser D, Fode P, Ritz E. Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. J Endocrinol Metab 1996; 81: 156-9.
103. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 2006; 60: 234-9.
104. Perna AF, Fadda GZ, Masry SG. Inhibition of phosphofructokinase activity in pancreatic islets in phosphate depletion. Miner Electrolyte Metab 1991; 17: 8-11.
105. Ditzel J, Sargeant L, Hadley WB. The relationship of abnormal vascular responses to retinopathy and nephropathy in diabetics. Arch Intern Med 1958; 101: 912-20.
106. Ditzel J, White P, Duckers J. Changes in the pattern of the smaller blood vessels in the bulbar conjunctiva in children of diabetic mothers. Diabetes 1954; 3: 99-106.
107. Ditzel J, White P, Sargeant LA. A follow-up study of children of young diabetic mothers. Acta Genet Stat Med 1957; 7: 101-4.
108. Häglin L, Lindblad Å, Bygren LO. Hypophosphataemia in the metabolic syndrome. Gender differences in body weight and blood glucose. Eur J Clin Nutr 2001; 55: 493-8.
109. Petersen KF, Dufour S, Shulman GI. Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents. PLoS Med 2005; 2: 879-84.
110. Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials. Diabetes, Metabolic Syndrome and Obesity: Targets Ther 2009; 2: 173-7.
111. Natelson S, Klein M, Kramer B. The effect of oral administration of calcium fructose diphosphate on the serum organic phosphate, inorganic phosphate, calcium, protein, and citric acid levels. J Clin Invest 1951; 30: 50-4.
112. Hardin C, Lazzarino G, Tavazzi B, et al. Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter. Am J Physiol 2001; 281: H2654-60.
113. Markow AK, Neely WA, Didioki RH, Terry J 3rd, Causey A, Le-han PH. Metabolic response of Fructose 1, 6-diphosphate in healthy subjects. Metabolism 2000; 49: 698-703.
114. Takeuchi K, Cao-Danh H, Friehs I, et al. Administration of fructose 1,6 diphosphate during early reperfusion significantly improves recovery of contractile function in postischemic heart. J Thorac Cardiovasc Surg 1998; 116: 335-43.
115. Antunes N, Martnusso CA, Takiya CM, et al. Fructose-1, 6 diphosphate as a protective agent for experimental ischemic acute renal failure. Kidney Int 2006; 69: 68-72.
116. Urso L, Brillante C, Orlandi M, Rotundo M, Ballati S. Evaluation of fructose-1, 6-diphosphate on erythrocyte 2, 3 diphosphoglycerate and ATP in surgical orthopedic patients. Aggressologie 1982; 23: 115-7.